Newsroom

Photo of Prof Josef Penninger
News
From 1 July 2023, Professor Josef Penninger takes over the Scientific Management of the Helmholtz Centre for Infection Research (HZI). Penninger is internationally renowned for his outstanding contributions to genetic and molecular biology. Joining HZI from the University of British Columbia (Canada), where he had led the Life Sciences Institute, he starts his position as head of the interdisciplinary infection research center in Braunschweig. Penninger is taking over the role of Professor Dirk Heinz, who had led the research center since 2011.
27.06.2023
Child with sample
News
At first glance, nature conservation and antibiotics have little in common. However, a new collaboration project between the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and the Naturlandstiftung Saar (NLS) shows that there is a great deal of overlap. In particularly species-rich habitats, scientists are looking for soil bacteria that produce new starting materials for antibiotic development. What is special about this project is that the search for the bacteria takes place within the framework of a citizen science campaign, in which interested citizens are directly involved in the scientific process and at the same time receive valuable information about local biodiversity. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with Saarland University.
21.06.2023
Fireside Chat mit Michael Manns, Dirk Heinz und Wolfgang Brückner
News
Yesterday, the official go-ahead was given for Lower Saxony's new lighthouse project. At the first public event of the Institute for Biomedical Translation (IBT) Lower Saxony, a top-class jury selected the pilot project of the initiative, which will receive funding of 1.5 million euros: Researchers at the University Medical Center Göttingen will be supported in the fight against chronic kidney diseases. A total of 25 million euros will be available to the IBT Lower Saxony for the next five years to accelerate the transfer of cutting-edge research in the life sciences in Lower Saxony and to bring it to the world in the form of start-ups and entrepreneurial ideas. The founding institutions of the IBT are the Hannover Medical School (MHH), the University Medical Center Göttingen (UMG) and the Helmholtz Centre for Infection Research (HZI) in Braunschweig.
17.06.2023
Fluoreszenzmikroskopische Aufnahme von auf Lungenepithelzellen gedruckten Biofilmen
News
Some bacterial pathogens form so-called biofilms during infection processes to protect themselves from drugs or cells of the human immune system. Every year, more than 500,000 people die from infections associated with biofilms. Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now developed a novel method to place such biofilms on lung cells in the laboratory. The model system produced by means of "bioprinting" should help to better understand infection processes and assist in the development of new active substances. The researchers have published their results in the journal Biofabrication.
13.06.2023
Group photo from the Inhoffen Lecture 2023: Stefan Schulz, Jörn Piel, Klemens Rottner, Dirk Heinz.
News
Many active substances used in medicine are based on naturally occurring products. However, the producers of these substances often do not grow or grow poorly under laboratory conditions. This also applies to marine invertebrates such as sponges, which live in close association with bacteria. Aided by synthetic biology, complex natural substances can also be engineered in the laboratory independently from their natural producers. For the scientific work on natural products from marine sources, the Friends of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Technische Universität Braunschweig are awarding Prof Jörn Piel from the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland, the Inhoffen Medal 2023. The award ceremony took place on 8 June 2023 at the HZI in Braunschweig.
09.06.2023
Modell
News
Antibiotics affect the composition and dynamics of the gut microbiome. Treatment with antibiotics not only leads to a loss of biodiversity of microorganisms, but also often favours the selection of resistant strains of bacteria. It has been unclear how the microbiome responds to repeated antibiotic therapy. In a preclinical study, an international research team led by two scientists from Ludwig-Maximilians-Universität München (LMU) and the Helmholtz Centre for Infection Research (HZI) in Braunschweig used metagenome and cultivation analyses to identify evolutionary mechanisms that contribute to the resilience of the microbial community after repeated antibiotic administration. The corresponding authors Prof Bärbel Stecher (LMU) and Prof Alice McHardy (HZI) both also conduct research at the German Center for Infection Research (DZIF). The study has now been published in the renowned scientific journal Cell Host & Microbe.
08.06.2023

HZI in the media

new antiviral medicines, says virologist Christian Sieben of the Helmholtz Centre for Infection Research in Germany.

 

Earlier in 2025, for

10.11.2025
|
The Press

Hochschule Hannover, die Universitätsmedizin Göttingen, das Helmholtz-Zentrum für Infektionsforschung in Braunschweig sowie die KI-

07.11.2025
|
Heise online

... , Leiter der Forschungsgruppe Mikrobielle Wirkstoffe am Helmholtz-Zentrum für Infektionsforschung, zu bedenken. Das erste ...

07.11.2025
|
Leipziger Volkszeitung (LVZ)

Quelle: Pressemitteilung

 

HZI-Helmholtz Zentrum für Infektionsforschung ...

04.11.2025
|
LaborPraxis

Forschende des Helmholtz-Zentrums für Infektionsforschung und der Universität Würzburg entwickeln derzeit einen Kaugummi, der Grippeviren

04.11.2025
|
Arbeitsmedizin-Sozialmedizin-Umweltmedizin

... Vakzinologie und angewandte Mikrobiologie am Helmholtz-Zentrum für Infektionsforschung. Die M2-Membranproteinhemmer verhindern ...

02.11.2025
|
Augsburger Allgemeine

... etwas dran ist“, erklärt Biologe Marc Stadler vom Helmholtz-Zentrum für Infektionsforschung gegenüber der Barmer-Krankenkasse. „Es ...

30.10.2025
|
bild der wissenschaft

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025
|
MSN.com

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025
|
innovations report

this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss

22.10.2025
|
Phys.org

Malaria-Medikamentes ermöglichen könnte. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

22.10.2025
|
Verband Deutscher Biologen e.V.

(Bild: DOI: 10.1021/jacs.5c08354 / Hips / CC BY 4.0) Wissenschaftler am Hips entwickelten eine Plattform zur Produktion von Furanoliden, die effektiv gegen Bakterien und Krebszellen wirken können und vielversprechende Wirkstoffe darstellen.

21.10.2025
|
PROCESS

Register now for the HZI-Newsletter